MicroRNA 3158-1 (MIR3158-1)

MicroRNA 3158-1 (MIR3158-1) is a short, non-coding RNA molecule of 20-24 nucleotides that belongs to the microRNA class. It participates in post-transcriptional gene regulation by affecting the stability and translation of target mRNAs, primarily through the RNA-induced silencing complex (RISC). MIR3158-1 is processed from a longer primary transcript via enzymatic cleavage by Drosha and Dicer. MicroRNAs like MIR3158-1 are implicated in various diseases by modulating key genetic networks, including roles in oncology as disease classifiers and regulatory molecules; for MIR3158-1 specifically, diseases associated include chromosome 15q13.3 deletion syndrome and malaria. There is currently no evidence that MIR3158-1 is directly targeted by approved drugs or widely used as a direct therapeutic target or biomarker. MIR3158-1 is a microRNA, which is a regulatory non-coding RNA rather than a protein-coding therapeutic target such as a receptor, enzyme, or channel. There is no standard or direct use of MIR3158-1 as a drug target, nor evidence of interacting drugs, nor defined safety concerns from current literature. Biological functions and disease roles are extrapolated based on canonical microRNA biology and specific database associations.

Other names

hsa-mir-3158-1mir-3158-1microRNA 3158-1